I agree that this site is using cookies. You can find further informations here.
X
Gingrich, Diane E.
150  results:
Search for persons X
?
1

Discovery of Clinical Candidate CEP-37440, a Selective Inhi..:

Ott, Gregory R. ; Cheng, Mangeng ; Learn, Keith S....
Journal of Medicinal Chemistry.  59 (2016)  16 - p. 7478-7496 , 2016
Link: https://doi.org/10.1021/..
 
?
2

Development and Scale-Up of an Optimized Route to the ALK I..:

Allwein, Shawn P. ; Roemmele, Renee C. ; Haley Jr., James J....
Organic Process Research & Development.  16 (2012)  1 - p. 148-155 , 2012
Link: https://doi.org/10.1021/..
 
?
3

Discovery of an Orally Efficacious Inhibitor of Anaplastic ..:

Gingrich, Diane E. ; Lisko, Joseph G. ; Curry, Matthew A....
Journal of Medicinal Chemistry.  55 (2012)  10 - p. 4580-4593 , 2012
Link: https://doi.org/10.1021/..
 
?
4

Optimization of a novel kinase inhibitor scaffold for the d..:

Zificsak, Craig A. ; Gingrich, Diane E. ; Breslin, Henry J....
Bioorganic & Medicinal Chemistry Letters.  22 (2012)  1 - p. 133-137 , 2012
Link: https://doi.org/10.1016/..
 
?
5

A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyrid..:

Dugan, Benjamin J. ; Gingrich, Diane E. ; Mesaros, Eugen F....
Journal of Medicinal Chemistry.  55 (2012)  11 - p. 5243-5254 , 2012
Link: https://doi.org/10.1021/..
 
?
6

2,7-Disubstituted-Pyrrolotriazine Kinase Inhibitors with an..:

Wells-Knecht, Kevin J. ; Ott, Gregory R. ; Cheng, Mangeng...
Chemical Research in Toxicology.  24 (2011)  11 - p. 1994-2003 , 2011
Link: https://doi.org/10.1021/..
 
?
7

2,7-Disubstituted-pyrrolo[2,1-f][1,2,4]triazines: New Varia..:

Ott, Gregory R. ; Wells, Gregory J. ; Thieu, Tho V....
Journal of Medicinal Chemistry.  54 (2011)  18 - p. 6328-6341 , 2011
Link: https://doi.org/10.1021/..
 
?
8

A highly selective, orally active inhibitor of Janus kinase..:

Stump, Kristine L ; Lu, Lily D ; Dobrzanski, Pawel...
Arthritis Research & Therapy.  13 (2011)  2 - p. R68 , 2011
Link: https://doi.org/10.1186/..
 
?
9

2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: Modi..:

Weinberg, Linda R. ; Albom, Mark S. ; Angeles, Thelma S....
Bioorganic & Medicinal Chemistry Letters.  21 (2011)  24 - p. 7325-7330 , 2011
Link: https://doi.org/10.1016/..
 
?
10

Advances in the development of kinase inhibitor therapeutic..:

Savage, Mary J. ; Gingrich, Diane E.
Drug Development Research.  70 (2009)  2 - p. 125-144 , 2009
Link: https://doi.org/10.1002/..
 
?
11

Synthesis, Modeling, and In Vitro Activity of (3'S)-epi-K-2..:

Gingrich, Diane E. ; Yang, Shi X. ; Gessner, George W...
Journal of Medicinal Chemistry.  48 (2005)  11 - p. 3776-3783 , 2005
Link: https://doi.org/10.1021/..
 
?
12

A New Class of Potent Vascular Endothelial Growth Factor Re..:

Gingrich, Diane E. ; Reddy, Dandu R. ; Iqbal, Mohamed A....
Journal of Medicinal Chemistry.  46 (2003)  25 - p. 5375-5388 , 2003
Link: https://doi.org/10.1021/..
 
?
13

Synthesis and kinase inhibitory activity of 3′-(S)-epi-K-25..:

Gingrich, Diane E. ; Hudkins, Robert L.
Bioorganic & Medicinal Chemistry Letters.  12 (2002)  20 - p. 2829-2831 , 2002
Link: https://doi.org/10.1016/..
 
?
14

A novel, one-pot preparation ofN-methyl-α-amino acid dipept..:

Dorow, R.L. ; Gingrich, Diane E.
Tetrahedron Letters.  40 (1999)  3 - p. 467-470 , 1999
Link: https://doi.org/10.1016/..
 
?
15

Inhibition of metalloproteinase by futoenone derivatives:

Yeh, Li-An ; Chen, James ; Baculi, Frans..
Bioorganic & Medicinal Chemistry Letters.  5 (1995)  15 - p. 1637-1642 , 1995
Link: https://doi.org/10.1016/..
 
1-15